The results showed the mRNA expression levels of JUN, IL-1β, IL-2, ICAM1, HMOX1, MMP9, MMP2, PTGS2, and TNF had significant difference in control group, ginsenoside group, and polysaccharide group, which suggested that ginsenoside and polysaccharide might have therapeutic potential for the treatment of lung adenocarcinoma by targeting the above-mentioned core genes (Figure 6). This evidence concerns the gene PTGS2 and lung adenocarcinoma.